Compounds and Drug Delivery for Diabetes Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (30 September 2025) | Viewed by 1092
Special Issue Editors
Interests: diabetes; drug discovery; drug delivery
Special Issue Information
Dear Colleagues,
Innovations in drug discovery and delivery have revolutionized the management of diabetes mellitus. Reports suggests that diabetes prevalence remains high on a global scale and is projected to increase in the future. Therefore, we must continue to search for potential pharmacological agents that complement existing pharmacotherapeutic options. Furthermore, adequate glycaemic control and adverse drug effects are directly linked to the pharmacokinetic and pharmacodynamic profiles of drugs, highlighting the necessity to explore drug delivery systems that can improve diabetes management. Technological advancements in drug delivery could enable us to overcome some of the challenges associated with diabetes management, therefore improving pharmacotherapeutic outcomes.
This Special Issue aims to showcase cutting-edge research on drug discovery and delivery strategies for diabetes mellitus. Accordingly, we welcome contributions on the discovery and development of drugs (containing synthetic and natural compounds) that target diabetes mellitus and their associated complications. Furthermore, we seek contributions on innovative drug delivery research and strategies to improve the management of diabetes.
Dr. Ntethelelo Sibiya
Dr. Andile Khathi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- antidiabetic compounds
- delivery systems
- glycaemic control
- insulin
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
